Lithium as a Therapeutic Approach to Attenuate Synaptic Deficits after TBI
Lithium as a Therapeutic Approach to Attenuate Synaptic Deficits after TBI
批准号:
8977261
负责人:
SHAUN CARLSON
金额:
$5.42万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-30 至 2017-09-29
关键词:
AcetylcholineAcuteAminobutyric AcidsAttenuatedBehavioralBiological AssayBrainBrain regionCalciumCell SurvivalCessation of lifeClinical TrialsComplexDataDendritic SpinesDevelopmentDockingEvaluationFunctional disorderGlutamatesHigh Pressure Liquid ChromatographyHippocampus (Brain)HistologyHourImmunoblottingImpaired cognitionImpairmentInjuryKnockout MiceLearningLeftLithiumMediatingMembraneMemoryMicrodialysisMolecular ChaperonesMorphologyMotorN-ethylmaleimide-sensitive proteinNamesNeurobehavioral ManifestationsNeuronsNeurotransmittersPathologyPatientsPhasePhysiologic MonitoringPolymerase Chain ReactionPropertyProteinsQuality of lifeRattusRecoveryRecovery of FunctionResearch Project GrantsRoleS-nitro-N-acetylpenicillamineSNAP receptorSpecificitySurvivorsSynapsesSynaptic CleftSynaptic MembranesSynaptic VesiclesSynaptic plasticityTherapeuticTherapeutic EffectTherapeutic InterventionThree-dimensional analysisTimeTransmission Electron MicroscopyTraumatic Brain InjuryTraumatic Brain Injury recoveryVAMP-2Workalpha synucleinbasecognitive abilitycysteine string proteindensityefficacy testingimprovedinjuredinsightmotor disordermouse modelneurobehavioralneurotransmissionneurotransmitter releasenovelpresynapticpublic health relevancereceptorreconstructionsynaptic functionsyntaxin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A TBI produces complex pathophysiology contributing to progressive cellular dysfunction and death that can culminate in impaired motor and cognitive abilities. Despite advances in understanding the multifaceted pathobiology of traumatic brain injury (TBI), no therapeutic has been approved for the treatment of TBI in clinical
trials. Previous work from our lab demonstrates that deficits in acetylcholine release in the hippocampus contribute to the manifestation of neurobehavioral dysfunction after injury, but little
is known about the mechanisms underlying impaired neurotransmission. In the uninjured brain, the formation of the N- ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex facilitates vesicular docking and neurotransmitter release; however, the effects of TBI on the SNARE complex have not been examined. We hypothesize that alterations in the SNARE complex and synaptic vesicle distribution contribute to impaired neurotransmission and behavioral dysfunction after TBI. The proposed work will test the efficacy of lithium to attenuate intrasynaptic impairments, promote synaptic plasticity and cell survival, and improve neurobehavioral function after TBI. To this end, we will utilize rat and mouse models of TBI to examine the therapeutic capacity of lithium. Additionally, we will examine the specificity of lithium's action in the synapse using commercially available cysteine string protein alpha (CSPa) knockout mice. In Aim 1, we will evaluate the effect of lithium on SNARE protein abundance and complex formation at multiple time points after TBI. Additionally, we will examine the effect of lithium on synaptic vesicular distribution and density and neurotransmitter release after TBI by transmission electron microscopy and microdialysis, respectively. In Aim 2, we will examine the effect of lithium on synaptic plasticity, hippocampal neuron survival, and neurobehavioral function in the weeks following TBI. The proposed work will provide the first evaluation of changes in synaptic vesicle distribution and alterations in the SNARE complex after TBI. Successful completion of this work will provide valuable insights into our understanding of synaptic dysfunction and the development of lithium based approaches to promote recovery in the injured brain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synaptic Vesicular Alterations after Traumatic Brain Injury
-
批准号:10683248
-
项目类别:
-
资助金额:$42.48万
-
财政年份:2022
-
负责人:SHAUN CARLSON
-
依托单位:
SV2A as a Therapeutic Target for Improved Neurotransmission after Traumatic Brain Injury
-
批准号:9893546
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2019
-
负责人:SHAUN CARLSON
-
依托单位:
SV2A as a Therapeutic Target for Improved Neurotransmission after Traumatic Brain Injury
-
批准号:10017359
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2019
-
负责人:SHAUN CARLSON
-
依托单位:
Lithium as a Therapeutic Approach to Attenuate Synaptic Deficits after TBI
-
批准号:9177697
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2015
-
负责人:SHAUN CARLSON
-
依托单位:
海外基金